City of Hope® Cancer Center Duarte is a nationally recognized center of excellence in the treatment of amyloidosis, a rare condition in which proteins called amyloids become abnormally shaped and are deposited on tissue or organs inside the body, potentially causing damage to how the body functions.
Our Los Angeles-area amyloidosis care team is dedicated to providing patients across Southern California with access to leading-edge diagnostic and treatment options for multiple types of amyloidosis. As a renowned research center, City of Hope is also on the forefront of research into this and many other rare disorders.
Amyloidosis Care in Los Angeles
City of Hope’s multidisciplinary team of amyloidosis experts works together to diagnose, treat and research new therapies for many types of the disease, including light-chain amyloidosis (AL), transthyretin amyloidosis (ATTR) and several other subtypes. Because amyloidosis can affect multiple different parts of the body, such as the heart, kidneys, nervous system and gastrointestinal system, our amyloidosis team includes specialists in multiple fields, including:
- Hematologists with expertise in multiple kinds of blood disorders
- Cardiologists specializing in heart health
- Neurologists, who help diagnose and treat issues with the central nervous system
- Nephrologists, who are specialists in kidney diseases and dysfunction
As a founding member of the National Comprehensive Cancer Network and a Top 10 “Best Hospital” for cancer, according to U.S. News & World Report’s 2025-26 rankings, City of Hope Duarte is ideally placed to bring together excellence in clinical care with leading-edge research studies designed to help build a stronger standard of care for amyloidosis patients in the Los Angeles area and beyond.
What Sets Our L.A.-Area Amyloidosis Program Apart?
At City of Hope Duarte, patients have access to leading-edge treatment options for amyloidosis and are cared for with compassion by doctors, nurses and other specialists with expertise in light-chain amyloidosis (AL), transthyretin amyloidosis (ATTR) and other forms of the disease. The benefits of receiving treatment at City of Hope include:
- A dedicated outpatient amyloidosis program, which offers comprehensive care for all forms of amyloidosis and a wide range of innovative treatment options, including stem cell transplantation and cellular therapy
- Clinical amyloidosis experts who have led transformational research in diagnosing this disease, differentiating AL from ATTR and treating these conditions
- State-of-the-art diagnostic imaging capabilities to more accurately diagnose amyloidosis, including the latest echocardiography, cardiac MRI and nuclear medicine scans
- Experience using Congo Red staining, the gold standard in detecting amyloidosis in tissue samples
- A multidisciplinary care team of heart, kidney, nervous system and other amyloid specialists working together to provide care for every patient
- Expertise in the treatment and management of AL, ATTR and cardiac amyloidosis
- Access to City of Hope’s renowned hematologic malignancies program
- Seamless coordination of care between cardiologists, hematologists, nephrologists and other experts
- Partnership with Mayo Clinic, which evaluates our biopsy tissues for disease subtyping using liquid chromatography evaluation
Our Amyloidosis Experts
City of Hope’s Los Angeles-area amyloidosis program includes nationally recognized experts in treating this rare condition. Our physicians are committed to helping each patient understand his or her unique diagnosis and make informed decisions about the best treatment or management options for them. Our experts have led pivotal amyloidosis research projects leading to breakthroughs in diagnosing and treating this condition.
Michael Rosenzweig, M.D., is Chief, Division of Multiple Myeloma and a hematologist-oncologist, in the Department of Hematology & Hematopoietic Cell Transplantation at City of Hope in Duarte, CA.
Sarah S. Lee, M.D., is an assistant clinical professor in the Department of Hematology & Hematopoietic Cell Transplantation, who studies precision therapy for plasma cell disorders like multiple myeloma and amyloidosis.
Faizi Jamal, M.D., is a cardiologist and associate clinical professor in the Division of Cardiology, Department of Medicine, at City of Hope.
Connect With Our Los Angeles Amyloidosis Team
City of Hope’s amyloidosis team provides patients in Los Angeles and beyond with access to highly accurate diagnosis options, breakthrough treatments and compassionate, multidisciplinary care. Call us today to start the process of getting a second opinion or becoming a patient.
